CR钼靶联合彩色多普勒超声检查对乳腺癌的诊断价值

Diagnostic value of CR molybdenum target combined with color Doppler ultrasonography in breast cancer

目的探讨CR钼靶联合彩色多普勒超声检查对乳腺癌的诊断价值。方法收集CR钼靶检查(CDUS)、彩色多普勒检查(CDUS)及病理资料完整的75例乳腺癌和30例乳腺良性病变患者的病历资料,统计分析CR钼靶和CDUS两种检查方法单独及联合使用对乳腺癌诊断率的差异。结果 CR钼靶单独诊断乳腺癌65例,诊断符合率为85.71%;CDUS单独诊断乳腺癌59例,诊断率符合为80.95%;两者联合诊断乳腺癌72例,诊断符合率为95.24%,较两种方法单独使用诊断率明显提高,差异有统计学意义(P<0.05)。结论 CR钼靶与CDUS联合检查可以提高乳腺癌的诊断率,对于乳腺癌的早发现、早诊断、早治疗有重要的临床价值。

Objective To investigate the diagnostic value of CR molybdenum target combined with color Doppler ultrasonography in breast cancer. Methods CR mammography, color Doppler and pathological data were completed for 75 cases of breast cancer and 30 cases of benign breast lesion to statistically analyze the difference in diagnostic rate of breast cancer between two inspection therapies, by using CR mammography or color Doppler ultrasonography separately and by using the two Methods together. Results Sixty-five patients with breast cancer were diagnosed by CR mammography alone, with diagnosis rate of 85.71%. Fifty-nine patients were diagnosed by color Doppler ultrasonography alone, with diagnosis rate of 80. 95%. Seventy-two patients were diagnosed by the combination therapy, with diagnosis rate of 95.24%. The diagnostic rate markedly improved by using the two Methods separately. There was significant difference between the two inspection therapies （ P 〈 0. 05 ）. Conclusions CR mammography combined with color Doppler ultrasonography can improve the diagnosis rate of breast cancer. Early detection, early diagnosis and early treatment are important for breast cancer in clinic.